ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

2-デオキシ-D-グルコース

2-Deoxyglucose

HCID 108223
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
154-17-6
標準SMILES
O=CC[C@@H](O)[C@H](O)[C@H](O)CO
InChIKey
VRYALKFFQXWPIH-PBXRRBTRSA-N
分子式
C6H12O5
平均分子量
164.16 g/mol
単同位体質量
164.06847348

概要

2-deoxyglucose is predominantly used as a diagnostic agent in its radiolabelled form (fluorine-18 is used as the radiolabel). By using positron emission tomography (PET), radiolabelled 2-deoxyglucose can determine glucose metabolism, which is altered in diseases such as cardiovascular disease, tumors, and Alzheimer's disease. Therapeutically, 2-deoxyglucose is an investigational drug that is being studied as an anticancer and antiviral agent. Concerning the former, 2- deoxyglucose was used as an adjunct to chemotherapy and radiotherapy in the treatment of solid tumors (lung, breast, pancreas, head, neck, and gastric tumors). The exact mechanisms of action of 2-deoxyglucose is still being investigated, but it is known that in hypoxic cancer cells, 2-deoxyglucose is a glycolysis inhibitor that prevents ATP production and, ultimately, cell survival. With respect to antiviral therapy, 2-deoxyglucose was shown to be effective against herpes simplex virus by affecting the virus' ability to penetrate cells. As an experimental drug, 2-deoxyglucose was demonstrated to work as an anticonvulsant in temporal lobe epilepsy. In this condition, 2-deoxyglucose represses the expression of certain proteins that are at high levels after a seizure. Although there are several possible therapeutic indications for 2-deoxyglucose, presently there is no approved indication for 2-deoxyglucose as a therapeutic agent.

名称と識別子

優先名称
2-Deoxyglucose
IUPAC
(3R,4S,5R)-3,4,5,6-tetrahydroxyhexanal
現地名
2-デオキシ-D-グルコース
英語名
2-Deoxy-D-glucose
分子式
C6H12O5
分子量
164.16

名称と別名

2-deoxy-D-glucose154-17-6Deoxyglucose(3R,4S,5R)-3,4,5,6-tetrahydroxyhexanal2-Desoxy-D-glucose2-Deoxy-D-mannoseD-2-DeoxyglucoseD-arabino-2-desoxyhexose2 Deoxyglucose2 Deoxy D glucose2 Desoxy D glucoseD-Arabino-hexose, 2-deoxy-
名称をさらに表示
2-デオキシ-D-グルコース2-デオキシグルコース2-デオキシ-D-arabino-ヘキソースデオキシグルコース2‐デオキシグルコ-ス2‐デオキシ‐D‐グルコース2-dg2-DEOXYGLUCOSE2-Dexoy-D-GlucoseD-Arabino-2-deoxyhexose2-deoxy-d-[UL-13C6]glucose(4R,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triolba2758
9G2MP84A8WDTXSID1037648GlyTouCan:G23624QENSC 15193BA-2758NSC-15193RefChem:471277CHEBI:15866

データベース識別子

CAS
154-17-6、61-58-5

物性

構造計算による物性

XLogP
-2.9
極性表面積
98 Ų
水素結合供与体数
4
水素結合受容体数
5
回転可能結合数
5
重原子数
11
形式電荷
0
複雑度
116

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
Boiling PointDecomposes
Melting Point147°C (296.6°F)
Collision Cross Section136.7 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

物理化学的性質

融点
146 · 146-147 °C(lit.)
比旋光度
45.5 · 45.5 º (c=2, H2O)
沸点
211.61 °C · 211.61°C (rough estimate)
比重(密度)
1.1738 · 1.1738 (rough estimate)
屈折率
46.5 ° · 46.5 ° (C=1, H2O)
貯蔵温度
2 · 2-8°C
溶解性
2 O: · H2O: 50 mg/mL 無色透明~微黄色
外見
結晶性
酸解離定数(Pka)
1 · pK1:12.52 (25°C)
色
白い
由来生物
synthetic
水溶解度
水に溶ける。

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 3 件

This chemical does not meet GHS hazard criteria for 100% (2 of 2) of all reports.

Not Classified

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory.

危険有害性情報

Regulatory Information · 2 件

Chemical: D-arabino-Hexose, 2-deoxy-

D-arabino-Hexose, 2-deoxy-: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - D-arabino-Hexose, 2-deoxy-: Environment tier I assessment
Hazard Classes and CategoriesNot Classified

毒性情報

Interactions · 5 件

2-DEOXYGLUCOSE INJECTED INTRAPERITONEALLY IN RATS IN LARGE DOSES CAUSED CHANGES IN THE ELECTRORETINOGRAM CONSISTING OF A DECR IN BOTH ALPHA- AND BETA-WAVES. THE EFFECT WAS ANTAGONIZED BY D-GLUCOSE.

SIMULTANEOUS ADMIN OF GLUCOSE @ DOSE EXCEEDING ITS MAX TUBULAR TRANSPORT CAPACITY INHIBITED TUBULAR REABSORPTION OF 2-DEOXYGLUCOSE. THUS, THE PROCESS OF TUBULAR REABSORPTION IS PROBABLY THE SAME AS THAT FOR GLUCOSE.

IN ANESTROUS SHEEP, 2-DEOXYGLUCOSE INFUSION INHIBITED LH RELEASE INDUCED BY ESTRADIOL BUT NOT BY LH-RH.

2-DEOXY-D-GLUCOSE INHIBITED REPAIR OF POTENTIALLY LETHAL DAMAGE INDUCED BY X-RAYS IN MOUSE EHRLICH ASCITES TUMOR CELLS.

For more Interactions (Complete) data for 2-DEOXY-D-GLUCOSE (6 total), please visit the HSDB record page.

Non-Human Toxicity Excerpts · 5 件

2-DEOXYGLUCOSE INJECTED INTRAPERITONEALLY IN RATS IN LARGE DOSES CAUSED CHANGES IN THE ELECTRORETINOGRAM CONSISTING OF A DECR IN BOTH ALPHA- AND BETA-WAVES.

化学と産業

薬理情報

PharmacodynamicsPhysiologically 2-deoxyglucose is an inhibitor of glycolysis, certain viruses, and seizures.
Mechanism of Action · 1 件

Solid tumors have hypoxic areas with slow growing cells that are resistant to chemotherapy, which attacks rapidly dividing cells. In the hypoxic area of the tumor, the cells rely on anaerobic glycolysis to produce energy in the form of ATP while non-tumor cells can rely on additional pathways such as fatty acid and amino acid metabolism to produce ATP. 2-deoxyglucose is an inhibitor of glycolysis because as a modified glucose molecule (it has a hydrogen at the carbon 2 position instead of a hydroxyl group), it is unable to complete the glycolysis process, and as such will hinder the survival of slow growing cancer cells. Regarding 2-deoxyglucose's antiviral activity, it prevents the glycosylation of specific proteins and lipids as well as prevents proper penetration of the virus into the target cells. In temporal lobe epilepsy, 2-deoxyglucose represses the overactive brain-derived neurotrophic factor (BDNF) promoter and prevents the increased expression of BDNF protein and TrkB receptor (BDNF's receptor) that is observed in epileptic patients.

Metabolism/Metabolites2-DEOXY-D-GLUCOSE WAS CONVERTED TO THE 6-PHOSPHATE IN MOUSE TESTIS AND LIVER AFTER IP INJECTION OF 50 MG/KG BODY WT DAILY FOR 7 DAYS.
MeSH Pharmacological Classification · 2 件

Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033)

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Absorption, Distribution and Excretion · 1 件

WHEN THE RENAL EXCRETION OF 2-DEOXYGLUCOSE WAS STUDIED IN DOGS AND RATS BY CONVENTIONAL CLEARANCE AND STOP-FLOW TECHNIQUES, IT WAS REABSORBED BY THE RENAL TUBULES AT AN AVG OF 68-89% OF THE FILTERED LOADS AND THE REABSORPTION SITE WAS IN THE PROXIMAL TUBULES.

関連反応

14 件
反応記録を作成
HRID 276096 の反応式
HRID 276096反応物として
HRID 390422 の反応式
HRID 390422反応物として
HRID 548538 の反応式
HRID 548538生成物として
HRID 729203 の反応式
HRID 729203生成物として
HRID 882657 の反応式
HRID 882657生成物として
HRID 1353987 の反応式
HRID 1353987生成物として
HRID 1434490 の反応式
HRID 1434490生成物として
HRID 1765917 の反応式
HRID 1765917生成物として
前へ1 / 2 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
PubChem CID
108223
DTXSID
DTXSID1037648
ChEMBL
CHEMBL1880349、CHEMBL2074932
UNII
9G2MP84A8W
EC Number
205-823-0
Nikkaji
J59.831C
Merck
14 · 14,2904
BRN
1723331 · 1723331
安定性
その水溶液は不安定で、使用時には現場で調製する必要があります。
InChI
1S/C6H12O5/c7-2-1-4(9)6(11)5(10)3-8/h2,4-6,8-11H,1,3H2/t4-,5-,6+/m1/s1
InChIKey
PMMURAAUARKVCB-CEZCPVKQSA-N
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)CC=O
LogP
-1.46 · -1.460 (est)
CAS データベース
154 · 154-17-6(CAS DataBase Reference)
EPAの化学物質情報
2 · D-arabino-Hexose, 2-deoxy- (154-17-6)

化学的性質

化学的特性white to light yellow crystal powde

...120 MG/DAY /GIVEN TO RAT/ FROM THE 9TH THROUGH THE 20TH GESTATIONAL DAY... RESORPTIONS WERE 69% AND THE SURVIVING FETUSES WERE ALL MALFORMED. ANOPHTHALMIA, CLEFT LIP AND PALATE AND LESIONS OF THE EXTREMITIES WERE OBSERVED. ...GAVE 1 G/KG ON DAYS 8, 9, 10 OR 11 & FOUND NO MALFORMATIONS IN SURVIVING RAT FETUSES.

2-DEOXY-D-GLUCOSE (DGLC) SELECTIVELY INHIBITED VIRUS DNA SYNTHESIS IN HUMAN EMBRYONIC LUNG CELLS INFECTED WITH HUMAN CYTOMEGALOVIRUS (HCMV). THE EFFECTIVE CONCN OF DGLC WAS APPROX 10-FOLD HIGHER IN CULTURE MEDIUM CONTAINING GLUCOSE INSTEAD OF SODIUM PYRUVATE. VIRUS DNA SYNTHESIS COULD BE SELECTIVELY INHIBITED BY ADDN OF DGLC EVEN AFTER INITIATION OF HCMV DNA REPLICATION. APPARENTLY, DGLC INTERFERES WITH THE FUNCTION OF AN EARLY CHROMATIN-ASSOCIATED GLYCOPROTEIN ESSENTIAL FOR VIRUS DNA SYNTHESIS.

2-DEOXY-D-GLUCOSE (0.3-1.2 MOL) INJECTED INTO THE 3RD VENTRICLE OF RATS DEPRESSED APPETITE FOR 72 HR. THE BLOOD SUGAR WAS INCR FOR 48 HR, WHILE FREE FATTY ACID INITIALLY INCR BUT DECR BY 24 HR.

For more Non-Human Toxicity Excerpts (Complete) data for 2-DEOXY-D-GLUCOSE (7 total), please visit the HSDB record page.

安全データ

F
3-10
wgk
3
tsca
TSCA listed
rtecs
MQ3325000
hs_code
29400090
risk_code
20/21/22-36/37/38
hazard_code
Xn,Xi
safety_code
24/25-37/39-36-26
ストレージクラス
11 - Combustible Solids
有毒物質データの
154-17-6(Hazardous Substances Data)

用途と製造

Uses · 3 件

2-DEOXYGLUCOSE IS A GLUCOSE ANTIMETABOLITE, INHIBITING GLYCOLYSIS; IT IS A WIDELY USED RESEARCH TOOL TO STUDY GLUCOSE-DEPENDENT OR -MEDIATED REACTIONS

RESEARCH CHEMICAL

MEDICATION (VET)

U.S. Exports · 2 件

(1979) No Data

(1981) No Data

U.S. Imports · 2 件

(1979) No Data

(1981) No Data

U.S. Production · 2 件

(1979) No Data

(1981) No Data

Consumption PatternsESSENTIALLY 100% AS A RESEARCH CHEMICAL
General Manufacturing Information · 2 件

D-arabino-Hexose, 2-deoxy-: ACTIVE

THE DEOXYSUGARS SUCH AS 2-DEOXYGLUCOSE ARE POTENT HERBICIDES. 2-DEOXYGLUCOSE SPRAYED AT 100 G/ACRE COMPLETELY CONTROLLED PLANTAGO ASIATICA IN AGROPYRON KAMOCHI AND ELEUSINE INDICA.

応用分野 · 3 件

用途2-デオキシ-D-グルコース(2-Deoxy-D-glucose)は、2-ヒドロキシル基が水素原子に置換されたグルコース分子である。そのため解糖系による代謝を受けない。2-DGはホスホグルコースイソメラーゼを競合的に、ヘキソキナーゼを非競合的に阻害する。ほとんどの細胞において、グルコースヘキソキナーゼは2-デオキシグルコースをリン酸化し、(肝臓および腎臓を除いて)細胞内に2-デオキシグルコース6-リン酸を捕捉する[要出典]。ゆえに、標識された2-デオキシグコースは組織のグルコース利用とヘキソキナーゼ活性のよいマーカーとなる。多くのがんは、グルコース取り込みおよびヘキソキナーゼレベルが上昇している。トリチウムあるいは炭素14で標識された2-デオキシグルコースは、実験室での動物実験でリガンドとしてよく使用されており、組織切片化とオートラジオグラフィーによって分布を調べることができる。

用途有機合成(誘導体)原料。

使用2-deoxy-D-Glucose is a non-metabolizable glucose analog that inhibits phosphorylation of glucose by hexokinase, the first step of glycolysis. This results in the depletion in cellular ATP, the inhibition of protein glycosylation, and the disruption of ER quality control by inducing the unfolded protein response. 2-deoxy-D-Glucose has been shown to cause cell cycle inhibition and cell death in in vitro models of hypoxia, induce autophagy, increase reactive oxygen species production, activate AMPK, and block tumor cell growth in animal models.[Cayman Chemical]

調製方法 · 1 件

純化方法Crystallise 2-deoxy--D-glucose from MeOH/Me2CO, Me2CO or butanone to give a mixture of  and  anomers, m 142-144o, [] 18 +38o (35minutes) to +46o (c 0.5, H2O). Recrystallisation from isoPrOH gives mainly the -anomer m 134-136o , [ ] D +156o to +103o (c 0.9, pyridine). 1H NMR studies showed that at 44o in D2O the solution contained 36% of -pyranose and 64% of -pyranose sugar, but furanose structures were undetectable. [Snowden & Fischer J Am Chem Soc 69 1048 1947, derivatives: Bollinger & Schmidt Helv Chim Acta 34 989 1951; see Angyal & Pickles Aust J Chem 25 1711 1972 for ratio of isomers in solution, Beilstein 1 IV 4282.]

上流・下流製品情報

上流原料

D-threo-Hexos-5-ulose, cyclic 1-(1,3-propanediyl acetal) (9CI)D-arabino-Hexose, 2-deoxy-, cyclic 1,3-propanediyl acetal (9CI)D-arabino-Heptose, 2,3-dideoxy-4,5:6,7-bis-O-(1-methylethylidene)-